title: Circumventing glucocorticoid-mediated hyperinsulinemia via the activation of PPARalpha.
authors.forename: Nadia
authors.initials: N
authors.lastname: Bougarne
authors.forename: Réjane
authors.initials: R
authors.lastname: Paumelle
authors.forename: Guy
authors.initials: G
authors.lastname: Haegeman
authors.forename: Bart
authors.initials: B
authors.lastname: Staels
authors.forename: Karolien
authors.initials: K
authors.lastname: De Bosscher
mesh_terms: D011345:Fenofibrate / Q000627:therapeutic use*; D015870:Gene Expression; D005938:Glucocorticoids / Q000009:adverse effects* / Q000037:antagonists & inhibitors; D006801:Humans; D006946:Hyperinsulinism / Q000139:chemically induced / Q000188:drug therapy*; D000960:Hypolipidemic Agents / Q000627:therapeutic use*; D009369:Neoplasms / Q000188:drug therapy; D047493:PPAR alpha / Q000819:agonists*
chemical_list: D005938:Glucocorticoids; D000960:Hypolipidemic Agents; D047493:PPAR alpha; D011345:Fenofibrate